Stockreport

GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF May 2025 (received in July 2025) upon pricing and reimbursement approval of Iqirvo® (elafibranor) in three major European countries €33.5 million in revenues, includin [Read more]